Eikon Therapeutics, Inc. (EIKN)

NASDAQ: EIKN · Real-Time Price · USD

11.38

+0.50 (4.60%)

Sep 2, 2026, 4:00 PM EDT - Market closed

Eikon Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	142.61	104.9	129.18	112.78
Short-Term Investments	388.57	231.07	90.93	317.63
Cash & Short-Term Investments	531.18	335.98	220.11	430.41
Cash Growth	-	52.64%	-48.86%	-
Prepaid Expenses	15.4	12.54	7.38	6.01
Restricted Cash	0.4	0.4	0.4	-
Total Current Assets	546.98	348.92	227.89	436.43
Property, Plant & Equipment	224.21	233.86	259.13	86.88
Long-Term Deferred Charges	-	3.6	-	-
Other Long-Term Assets	8.38	8.35	4.22	2.4
Total Assets	779.57	594.73	491.24	525.71

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Accounts Payable	6.56	0.68	17.58	2.19
Accrued Expenses	39.29	44.16	29.16	21
Current Portion of Leases	9.45	10.03	9.31	5.05
Other Current Liabilities	-	0.14	0.4	3.21
Total Current Liabilities	55.3	55.01	56.45	31.44
Long-Term Leases	242.77	247.29	193.15	26.69
Other Long-Term Liabilities	-	10	5.35	0.73
Total Liabilities	313.07	312.3	254.95	58.86

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Common Stock	0.01	-	-	0
Additional Paid-In Capital	1,558	41.48	33.01	19.75
Retained Earnings	-1,092	-920.51	-604.94	-361.13
Total Common Equity	466.5	-879.03	-571.93	-341.37
Shareholders' Equity	466.5	282.44	236.29	466.85
Total Liabilities & Equity	779.57	594.73	491.24	525.71

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Total Debt	252.22	257.32	202.46	31.74
Net Cash (Debt)	278.96	78.66	17.65	398.68
Net Cash Growth	-	345.59%	-95.57%	-
Net Cash Per Share	11.88	27.18	7.01	196.75
Filing Date Shares Outstanding	54.17	54.14	2.87	2.03
Total Common Shares Outstanding	54.15	3.07	2.87	2.03
Working Capital	491.68	293.91	171.44	404.99
Book Value Per Share	8.62	-286.47	-199.28	-168.47
Tangible Book Value	466.5	-879.03	-571.93	-341.37
Tangible Book Value Per Share	8.62	-286.47	-199.28	-168.47
Machinery	59.18	58.97	54.36	49.47
Construction In Progress	0.74	0.62	96.86	5.42
Leasehold Improvements	120.59	120.59	18.61	18.34

SEC Filings: 10-K · 10-Q